A Study to Evaluate ALN-HTT02 in Adult Patients with Huntington’s Disease
ALN-HTT02-001
Phase 1 other active
Quick answer
A Study to Evaluate ALN-HTT02 in Adult Patients with Huntington’s Disease for Huntington’s disease is a Phase 1 program (other) at Alnylam Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alnylam Netherlands B.V.
- Indication
- Huntington’s disease
- Phase
- Phase 1
- Modality
- other
- Status
- active